» Articles » PMID: 2657323

Fasting Hyperglycemia in Non-insulin-dependent Diabetes Mellitus: Contributions of Excessive Hepatic Glucose Production and Impaired Tissue Glucose Uptake

Overview
Journal Metabolism
Specialty Endocrinology
Date 1989 Apr 1
PMID 2657323
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

The factors responsible for fasting hyperglycemia were investigated in 77 normal weight non-insulin-dependent diabetic (NIDD) and 72 age-, sex-, and weight-matched control individuals. In diabetic subjects with mild fasting hyperglycemia (less than 140 mg/dL) hepatic glucose production (1.85 +/- 0.03 mg/kg.min) was similar to controls (1.84 +/- 0.02); the major factor responsible for the elevated basal glucose level in the diabetic group was a decreased efficiency in the tissue uptake of glucose, as reflected by a 30% decline in the rate of glucose clearance (1.56 +/- 0.03 v 2.00 +/- 0.03 mL/kg.min, P less than .001). In contrast, in diabetic subjects with fasting plasma glucose concentrations above 140 mg/dL, basal hepatic glucose production was significantly elevated (2.42 +/- 0.08 mg/kg.min, P less than .001) and correlated closely with the increase in fasting plasma glucose concentration (r = .796, P less than .001). The basal rate of whole body glucose clearance reached a plateau value at fasting glucose levels of 160 to 180 mg/dL and did not contribute to the further rise in fasting plasma glucose concentrations above 160 to 180 mg/dL. Decreased efficiency of tissue glucose uptake is responsible the development of fasting hyperglycemia in patients with mild NIDDM (fasting plasma glucose less than 140 mg/dL). As the diabetic state worsens, an increase in basal hepatic glucose production is the major factor responsible for the progressive rise in fasting glucose levels.

Citing Articles

The Reproducibility and Reliability of Insulin Sensitivity and Secretion Indices in Children and Adolescents.

Hani N, Vajravelu M, Meijer J, McCaffery H, Sturza J, Dhadphale E Pediatr Diabetes. 2024; 2024.

PMID: 39726936 PMC: 11671114. DOI: 10.1155/2024/2136173.


Relationship between four insulin resistance surrogates and regression to normoglycemia from prediabetes among Chinese adults: A longitudinal Cohort Study.

Yang L, Feng Y, Wang Y, Liu C, Gao D Endocrine. 2024; 86(3):980-993.

PMID: 38965137 DOI: 10.1007/s12020-024-03947-5.


Assessing blood sugar measures for predicting new-onset diabetes and cardiovascular disease in community-dwelling adults.

Kim J, Lee Y, Nam C, Kwon Y, Lee J Endocrine. 2024; 86(2):528-538.

PMID: 38772989 DOI: 10.1007/s12020-024-03876-3.


Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review).

Varra F, Varras M, Varra V, Theodosis-Nobelos P Mol Med Rep. 2024; 29(6).

PMID: 38606791 PMC: 11025031. DOI: 10.3892/mmr.2024.13219.


The WCIRDC 2023: Concepts of insulin resistance.

Bloomgarden Z J Diabetes. 2024; 16(3):e13552.

PMID: 38516866 PMC: 10958406. DOI: 10.1111/1753-0407.13552.